• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗组胺药物治疗变应性鼻炎:不同途径,不同机制?

Antihistamines treatment for allergic rhinitis: different routes, different mechanisms?

机构信息

Miami Children's Hospital, Division of Allergy and Immunology, 3100 Southwest 62 Avenue, Miami, FL 33155, USA.

出版信息

Allergy Asthma Proc. 2009 Nov-Dec;30(6):584-8. doi: 10.2500/aap.2009.30.3289.

DOI:10.2500/aap.2009.30.3289
PMID:20031004
Abstract

Antihistamines have been used in the treatment of rhinitis since ancient times. Antihistamines can be used via oral or topical route for the treatment of allergic rhinitis, as well as nonallergic forms of rhinitis. The topical formulation of medications is the preferred treatment route used for many diseases. This article will investigate the differences in the route of antihistamines in the treatment of allergic rhinitis. A review of the literature was performed to investigate the differences between the use of oral and topical antihistamines in the treatment of allergic rhinitis. Antihistamines inhibit the mediators of inflammation that worsen the symptoms of allergic rhinitis. Intranasal and oral antihistamines are important options in the therapy of allergic rhinitis, and topical use may result in unexpected benefits to patients with allergic rhinitis.

摘要

抗组胺药自古以来就被用于治疗鼻炎。抗组胺药可通过口服或局部途径用于治疗过敏性鼻炎,以及非过敏性鼻炎。药物的局部制剂是许多疾病的首选治疗途径。本文将研究抗组胺药在治疗过敏性鼻炎中的途径差异。通过文献回顾,研究了口服和局部应用抗组胺药治疗过敏性鼻炎的差异。抗组胺药抑制加重过敏性鼻炎症状的炎症介质。鼻内和口服抗组胺药是过敏性鼻炎治疗的重要选择,局部使用可能会给过敏性鼻炎患者带来意想不到的益处。

相似文献

1
Antihistamines treatment for allergic rhinitis: different routes, different mechanisms?抗组胺药物治疗变应性鼻炎:不同途径,不同机制?
Allergy Asthma Proc. 2009 Nov-Dec;30(6):584-8. doi: 10.2500/aap.2009.30.3289.
2
Antihistamine treatment for allergic rhinitis: different routes, different outcomes?抗组胺药物治疗变应性鼻炎:不同途径,不同结局?
Allergy Asthma Proc. 2009 Nov-Dec;30(6):589-94. doi: 10.2500/aap.2009.30.3287.
3
Intranasal antihistamines for allergic rhinitis: mechanism of action.鼻腔抗组胺药治疗变应性鼻炎:作用机制。
Allergy Asthma Proc. 2009 Jul-Aug;30(4):345-8. doi: 10.2500/aap.2009.30.3263.
4
The efficacy of intranasal antihistamines in the treatment of allergic rhinitis.鼻内抗组胺药治疗变应性鼻炎的疗效。
Ann Allergy Asthma Immunol. 2011 Feb;106(2 Suppl):S6-S11. doi: 10.1016/j.anai.2010.08.010.
5
Intranasal antihistamines for allergic rhinitis: examining the clinical impact.鼻腔抗组胺药治疗过敏性鼻炎:观察临床疗效。
Allergy Asthma Proc. 2009 Jul-Aug;30(4):349-57. doi: 10.2500/aap.2009.30.3261.
6
Antihistamine therapy in allergic rhinitis.变应性鼻炎的抗组胺治疗。
Immunol Allergy Clin North Am. 2011 Aug;31(3):509-43. doi: 10.1016/j.iac.2011.05.003.
7
Intranasal antihistamines in the treatment of allergic rhinitis.鼻内用抗组胺药治疗变应性鼻炎。
Ann Allergy Asthma Immunol. 2011 Feb;106(2 Suppl):S1. doi: 10.1016/j.anai.2010.09.027.
8
Clinical assessment of antihistamines in rhinitis.抗组胺药在鼻炎中的临床评估
Clin Exp Allergy. 1999 Jul;29 Suppl 3:77-81.
9
First do no harm: managing antihistamine impairment in patients with allergic rhinitis.首要原则是不造成伤害:应对过敏性鼻炎患者的抗组胺药损伤问题。
J Allergy Clin Immunol. 2003 May;111(5):S835-42. doi: 10.1067/mai.2003.1550.
10
Comparison of intranasal corticosteroids and antihistamines in allergic rhinitis: a review of randomized, controlled trials.鼻内用皮质类固醇与抗组胺药治疗变应性鼻炎的比较:随机对照试验综述
Am J Respir Med. 2003;2(1):55-65. doi: 10.1007/BF03256639.

引用本文的文献

1
Administration Strategy-Dependent Mechanisms and Effects of Human Adipose Tissue Stem Cell Extracellular Vesicles in Mouse Allergic Rhinitis Treatment.人脂肪组织干细胞细胞外囊泡在小鼠过敏性鼻炎治疗中的给药策略依赖性机制及效果
Cell Transplant. 2025 Jan-Dec;34:9636897251325673. doi: 10.1177/09636897251325673. Epub 2025 Apr 3.
2
Chemical Stability Study of H Antihistaminic Drugs from the First and the Second Generations, Diphenhydramine, Azelastine and Bepotastine, in Pure APIs and in the Presence of Two Excipients, Citric Acid and Polyvinyl Alcohol.第一代和第二代 H 抗组胺药物(苯海拉明、氮卓斯汀和贝他斯汀)在纯原料药及两种赋形剂(柠檬酸和聚乙烯醇)存在下的化学稳定性研究
Molecules. 2022 Nov 29;27(23):8322. doi: 10.3390/molecules27238322.
3
Turkish Guideline for Diagnosis and Treatment of Allergic Rhinitis (ART).土耳其变应性鼻炎诊断与治疗指南(ART)
Turk Arch Otorhinolaryngol. 2021 May;59(Suppl 1):1-157. doi: 10.4274/tao.2021.suppl.1.
4
Azelastine enhances the clinical efficacy of glucocorticoid by modulating MKP-1 expression in allergic rhinitis.氮卓斯汀通过调节过敏性鼻炎中MKP-1的表达来增强糖皮质激素的临床疗效。
Eur Arch Otorhinolaryngol. 2015 May;272(5):1165-73. doi: 10.1007/s00405-014-3191-3. Epub 2014 Jul 25.
5
A four-way, double-blind, randomized, placebo controlled study to determine the efficacy and speed of azelastine nasal spray, versus loratadine, and cetirizine in adult subjects with allergen-induced seasonal allergic rhinitis.一项四向、双盲、随机、安慰剂对照研究,旨在确定氮卓斯汀鼻喷剂相对于氯雷他定和西替利嗪在成人变应原性季节性过敏性鼻炎患者中的疗效和起效速度。
Allergy Asthma Clin Immunol. 2013 May 1;9(1):16. doi: 10.1186/1710-1492-9-16. eCollection 2013.
6
Sequential engagement of FcεRI on Mast Cells and Basophil Histamine H(4) Receptor and FcεRI in Allergic Rhinitis.肥大细胞和嗜碱性粒细胞组胺 H(4)受体与 FcεRI 在变应性鼻炎中的顺序结合。
J Immunol. 2013 Jan 15;190(2):539-48. doi: 10.4049/jimmunol.1202049. Epub 2012 Dec 14.
7
C-027 inhibits IgE-mediated passive sensitization bronchoconstriction and acts as a histamine and serotonin antagonist in human airways.C-027 抑制 IgE 介导的被动致敏性支气管收缩,并作为组胺和 5-羟色胺拮抗剂在人体气道中发挥作用。
Allergy Asthma Proc. 2011 Sep-Oct;32(5):359-65. doi: 10.2500/aap.2011.32.3460.